» Articles » PMID: 30840605

ACG Clinical Guideline: Ulcerative Colitis in Adults

Overview
Specialty Gastroenterology
Date 2019 Mar 7
PMID 30840605
Citations 569
Authors
Affiliations
Soon will be listed here.
Abstract

Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the preferred approach to the management of adults with UC and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) process. In instances where the evidence was not appropriate for GRADE, but there was consensus of significant clinical merit, "key concept" statements were developed using expert consensus. These guidelines are meant to be broadly applicable and should be viewed as the preferred, but not only, approach to clinical scenarios.

Citing Articles

Biosilicification-mimicking chiral nanostructures for targeted treatment of inflammatory bowel disease.

Xu M, Xin W, Xu J, Wang A, Ma S, Dai D Nat Commun. 2025; 16(1):2551.

PMID: 40089457 DOI: 10.1038/s41467-025-57890-8.


Culture-based characterization of gut microbiota in inflammatory bowel disease.

Park H, Yeo S, Lee T, Han Y, Ryu C, Huh C Front Microbiol. 2025; 16:1538620.

PMID: 40051478 PMC: 11884817. DOI: 10.3389/fmicb.2025.1538620.


Prevalence and predictability of the Chicago Classification of Pouchitis in ulcerative colitis: a multicenter study in Japan.

Akiyama S, Hayashi R, Takasago T, Kusunoki K, Ikeuchi H, Takenaka K J Gastroenterol. 2025; .

PMID: 40050487 DOI: 10.1007/s00535-025-02231-1.


Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center.

St-Pierre J, Choi D, Fear E, Choi N, Mathew A, Cohen R Dig Dis Sci. 2025; .

PMID: 40048134 DOI: 10.1007/s10620-025-08950-y.


Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study.

Torres J, DHaens G, Regueiro M, Santana G, Panes J, Vermeire S Therap Adv Gastroenterol. 2025; 18:17562848251318849.

PMID: 40028509 PMC: 11869240. DOI: 10.1177/17562848251318849.